Metformin and Esomeprazole For Preterm Pre-eclampsia

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
Preeclampsia SeverePreeclampsia Second TrimesterPreterm Birth Complication
Interventions
DRUG

Esomeprazole 20mg

Combination 2 g of oral extended release metformin, Esomeprazole 20mg daily until delivery.

Trial Locations (1)

19713

Christiana Care Health Systems, Newark

All Listed Sponsors
lead

Christiana Care Health Services

OTHER

NCT05232994 - Metformin and Esomeprazole For Preterm Pre-eclampsia | Biotech Hunter | Biotech Hunter